Salvira™ Does Not Modulate Estrogen Receptor: Reassessing Salvia officinalis Proposed Phytoestrogenic Properties
Nutrients · 2026
DOI: 10.3390/nu18213497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Rossana Iannitti und 8 weiteren Autor:innen. Beteiligte Einrichtung: S&R Farmaceutici SpA, 06083 Bastia Umbra, Italy. Hauptthemen laut MEDLINE: Salvia officinalis, Estrogen Receptor alpha, Plant Extracts, Phytoestrogens. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Enterprises and Made in Italy.
Abstract (Originalsprache)
Background/Objectives: Salvia officinalis L. is widely used in food supplements, particularly those intended to support women’s health and alleviate menopausal vasomotor symptoms. However, the extent to which estrogen receptor signaling contributes to its reported clinical benefits remains unclear. Therefore, evaluating its potential endocrine activity is a key aspect of its toxicological characterization and overall safety assessment. The present study aimed to investigate the potential estrogenic effects of a standardized Italian Salvia officinalis L. extract (Salvira™), as well as its biological effects on estrogen-responsive breast cancer cells (MCF-7).
Methods
In vitro enzymatic assays and estrogen receptor alpha (ERα) agonist- and antagonist-mode experiments were performed to assess its ability to modulate ERα signaling. Moreover, cell viability, proliferation, and clonogenic capacity were assessed in MCF-7 cells following exposure to increasing concentrations of the extract.
Results
The extract did not exhibit estrogenic activity in all experimental dose–response assays. In MCF-7 cells, treatment with the sage extract did not produce an overall effect on cell viability or proliferative capacity. Moreover, no impairment of long-term clonogenic potential was observed at the tested concentrations.
Conclusions
Under the experimental conditions investigated, the present findings suggest that the standardized Salvia officinalis L. extract showed no evidence of estrogenic activity and did not induce relevant ERα-mediated biological effects in estrogen-responsive MCF-7 cells. These findings contribute to the characterization of the endocrine safety profile of the extract, supporting its safe use as an ingredient in food supplements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- S&R Farmaceutici SpA, 06083 Bastia Umbra, Italy.
- Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Via 8 Archirafi 30, 90123 Palermo, Italy.
- Technology Scientific S.r.l., Via del Quarnaro 14, 90144 Palermo, Italy.
- Dephi STARLab, Department of Pharmaceutical Sciences, University of Perugia, 06123 Perugia, Italy.
ORCID-Profile: Mariano Licciardi, Francesco Montalbano, Desirée Bartolini, Elisa Menicali, Alice Coletti
Förderung
- Italian Ministry of Enterprises and Made in Italy
Zitieren
APA
Iannitti, R., Ceccarelli, G., Melfi, V., Licciardi, M., Montalbano, F., Bartolini, D., Menicali, E., Coletti, A., & Pennetta, C. (2026). Salvira™ Does Not Modulate Estrogen Receptor: Reassessing Salvia officinalis Proposed Phytoestrogenic Properties. Nutrients. https://doi.org/10.3390/nu18213497
Vancouver
Iannitti R, Ceccarelli G, Melfi V, Licciardi M, Montalbano F, Bartolini D, et al. Salvira™ Does Not Modulate Estrogen Receptor: Reassessing Salvia officinalis Proposed Phytoestrogenic Properties. Nutrients. 2026. doi:10.3390/nu18213497
BibTeX
@article{Iannitti2026,
author = {Iannitti, Rossana and Ceccarelli, Giada and Melfi, Valentina and Licciardi, Mariano and Montalbano, Francesco and Bartolini, Desirée and Menicali, Elisa and Coletti, Alice and Pennetta, Chiara},
title = {Salvira™ Does Not Modulate Estrogen Receptor: Reassessing Salvia officinalis Proposed Phytoestrogenic Properties},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18213497}
}
EUVIMED